Liposomal formulation of Gp41 derivate with adjuvant MPLA: vaccine design, immunogenicity in animals and safety in humans

• Katinger D,
• Wagner A,
• Luque I,
• Crespillo S,
• Conejero-Lara F,
• Roger M,
• Martin C,
• Mouz N,
• Mourao S,
• Farsang A,
• Notka F,
• Malcolm K,
• Bosquet N,
• Le Grand R,
• Moog C,
• Cope A,
• Shattock R,
• Lewis DJ,
• El Habib R

Affiliations

Katinger D

Wagner A

Luque I

Crespillo S

Conejero-Lara F

Roger M

Martin C

Mouz N

Mourao S

Farsang A

Notka F

Malcolm K

Bosquet N

Le Grand R

Moog C

Cope A

Shattock R

Lewis DJ

El Habib R